A grant from Fighting Blindness Canada will allow Dave Gamm to further test the efficacy of an induced pluripotent stem cell (iPSC) derived treatment that aims to replace damaged photoreceptor cells and restore some measure of vision.
Research
El CDC Publicó Nuevos Números de la Prevalencia de Autismo
English Por, Emily Leclerc, Escritora Científica, Waisman Center El reporte comunitario en autismo de los Centros para el Control y la Prevención de Enfermedades (CDC, en inglés) reveló que la prevalencia de autismo en niños …
CDC releases new numbers on autism spectrum disorder prevalence
The Centers for Disease Control and Prevention’s recently released 2021 Community Report on Autism found that the prevalence of autism among eight-year-old children is continuing to increase.
New $11 million award to study intellectual disability in Down syndrome
Waisman investigators Anita Bhattacharyya, PhD, an assistant professor of cell and regenerative biology and Su-Chun Zhang, MD, PhD, professor of neuroscience and neurology at the School of Medicine and Public Health at UW-Madison, were awarded …
Genetics has a higher influence on brain microstructure development than the environment
Brain structure isn’t always the first thing that comes to mind when we think about what we inherited from our biological parents or share with our siblings. We mostly think about facial features, hair color, and even personality.
Promising treatment for Alexander disease moves from rat model to human clinical trials
Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition.
New research shows math anxiety can impact learning fractions
For many students, math is a tough subject that can have a lot of anxiety associated with it. Within math, fractions are often considered particularly hard.
CMT biomarkers for future treatments
A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
Studying the connection between Alzheimer’s and Down syndrome for Down syndrome awareness month
By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of …
A new computational pipeline connects disease and discovery at the cellular level
Could Alzheimer’s disease and schizophrenia be biologically connected?